T. Rowe Price Associates’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$61.7M Sell
1,865,977
-127,919
-6% -$4.23M 0.01% 680
2025
Q1
$80.1M Sell
1,993,896
-631,185
-24% -$25.4M 0.01% 594
2024
Q4
$123M Sell
2,625,081
-539,864
-17% -$25.4M 0.01% 528
2024
Q3
$167M Buy
3,164,945
+806,602
+34% +$42.6M 0.02% 468
2024
Q2
$128M Sell
2,358,343
-572,605
-20% -$31M 0.02% 493
2024
Q1
$205M Sell
2,930,948
-313,302
-10% -$22M 0.03% 416
2023
Q4
$271M Buy
3,244,250
+2,232,623
+221% +$186M 0.04% 358
2023
Q3
$29.8M Sell
1,011,627
-73,686
-7% -$2.17M ﹤0.01% 819
2023
Q2
$35.4M Sell
1,085,313
-86,716
-7% -$2.83M ﹤0.01% 797
2023
Q1
$41.2M Buy
1,172,029
+64,168
+6% +$2.26M 0.01% 733
2022
Q4
$50.8M Buy
1,107,861
+14,414
+1% +$660K 0.01% 657
2022
Q3
$53M Buy
1,093,447
+595,708
+120% +$28.9M 0.01% 630
2022
Q2
$19.6M Buy
497,739
+35,256
+8% +$1.39M ﹤0.01% 1167
2022
Q1
$17M Buy
462,483
+313,044
+209% +$11.5M ﹤0.01% 1266
2021
Q4
$6.81M Buy
149,439
+119,982
+407% +$5.47M ﹤0.01% 1462
2021
Q3
$1.05M Buy
29,457
+1,016
+4% +$36.3K ﹤0.01% 2035
2021
Q2
$563K Buy
28,441
+1,261
+5% +$25K ﹤0.01% 2328
2021
Q1
$632K Buy
27,180
+3,654
+16% +$85K ﹤0.01% 2247
2020
Q4
$489K Sell
23,526
-636,628
-96% -$13.2M ﹤0.01% 2246
2020
Q3
$14.3M Buy
+660,154
New +$14.3M ﹤0.01% 1219
2018
Q1
Sell
-427,148
Closed -$3.48M 2544
2017
Q4
$3.48M Buy
427,148
+1,890
+0.4% +$15.4K ﹤0.01% 1456
2017
Q3
$6.17M Buy
+425,258
New +$6.17M ﹤0.01% 1394
2013
Q4
Sell
-1,431,573
Closed -$10.9M 2490
2013
Q3
$10.9M Sell
1,431,573
-42,285
-3% -$321K ﹤0.01% 1249
2013
Q2
$17.1M Buy
+1,473,858
New +$17.1M ﹤0.01% 1109